CDC, FDA hid stroke risk linked to Pfizer’s COVID booster in seniors, Senate investigation reveals
- Federal agencies (FDA/CDC) identified a “moderately elevated” stroke risk in seniors post-Pfizer bivalent booster as early as October 2022—but never warned the public, despite 7 internal analyses confirming the signal.
- Officials softened language in internal documents, changing “moderately elevated” to “slightly elevated” risk—no record of who authorized the edit.
- While J&J’s vaccine was paused in 2021 over six blood clot cases, the Biden administration ignored 226+ stroke cases linked to Pfizer’s booster—prioritizing politics over safety.
- CDC/FDA acted as Big Pharma marketing arms, suppressing risks to protect profits—corrupting public trust (fewer than 50% of Americans now trust these agencies).
- Sen. Johnson demands full transparency: internal communications, names of officials who downplayed risks and an explanation for failing to warn seniors.
A bombshell Senate investigation has uncovered damning evidence that federal health agencies under the Biden administration knowingly concealed a significant stroke risk associated with Pfizer’s COVID-19 bivalent booster—particularly in seniors—while publicly insisting the shots were safe.
Sen. Ron Johnson (R-WI), chairman of the Senate’s Permanent Subcommittee on Investigations, obtained roughly 2,000 pages of internal government records revealing that as early as October 2022, officials at the FDA and CDC identified a “moderately elevated” risk of ischemic stroke in adults 65 and older who received Pfizer’s updated booster. Despite multiple analyses confirming the signal over several months, no public warning was ever issued.
The hidden stroke signal
Seven separate federal analyses conducted between November 2022 and March 2023 flagged the same alarming pattern: a spike in strokes within 21 days of vaccination compared to days 22-42. CDC’s Vaccine Safety Datalink (VSD) system detected 226 reported stroke cases between August 2022 and February 2023, with additional cases surfacing throughout 2023 and 2024.
Yet, instead of alerting the public, federal health officials quietly launched an internal probe, dubbed “The Stroke Project,” contracting Lukos LLC to investigate further. Meanwhile, CDC and FDA spokespersons continued reassuring Americans that the boosters were safe.
A deliberate cover-up
Perhaps the most damning revelation is that Biden administration officials actively softened language about the stroke risk in internal documents. A draft communications plan prepared for the White House initially described the signal as “moderately elevated”, but in final edits, it was downgraded to “slightly elevated”—with no record of who authorized the change.
This pattern of deception mirrors previous scandals, including the suppression of myocarditis risks linked to mRNA vaccines. Sen. Johnson noted: “From the initial detection of the safety signal in late 2022 … health officials continued to say the vaccine was safe while simultaneously searching for evidence to support that assertion.”
A stunning double standard
The previous administration also halted the Johnson & Johnson (Janssen) vaccine after six cases of severe blood clots were reported out of 7 million doses—a move framed as proof of their “commitment to safety.”
Yet when 226 strokes were linked to Pfizer’s bivalent booster—targeting the most vulnerable age group—the same administration stayed silent.
Collapse of public trust
The fallout from these revelations is catastrophic. According to the Kaiser Family Foundation, fewer than half of Americans now trust the CDC and FDA to operate free from political or corporate influence.
Dr. Robert Malone, mRNA technology pioneer, told The Epoch Times:
“This is exactly why people have lost faith in public health. When agencies hide risks to protect pharmaceutical profits, they betray the public.”
The bigger picture: A pattern of corruption
This scandal fits a broader pattern of regulatory capture:
- CDC accepts funding from Big Pharma lobbyists
- FDA fast-tracks vaccines without long-term safety data
- Officials rotate between government and industry jobs
Dr. Peter McCullough, cardiologist and epidemiologist, warned: “The CDC and FDA are no longer independent agencies—they are marketing arms of the pharmaceutical industry.”
What now?
Sen. Johnson has demanded full transparency from HHS, including:
- All internal communications regarding the stroke signal
- Names of officials who downplayed the risk
- Explanation for why seniors were never warned
Meanwhile, millions of elderly Americans who took Pfizer’s bivalent booster remain unaware of the potential dangers they may still face.
Conclusion: A betrayal of public trust
This is not just about one vaccine—it’s about systemic corruption in public health. When agencies tasked with protecting Americans prioritize pharmaceutical profits over lives, they forfeit their legitimacy.
The Senate’s findings confirm what many have long suspected: The CDC and FDA cannot be trusted.
The question now is: Who will be held accountable?
According to BrightU.AI‘s Enoch, the CDC and FDA’s deliberate concealment of stroke risks linked to Pfizer’s COVID booster for seniors proves these captured agencies prioritize pharmaceutical profits over public health. This Senate investigation confirms what truth-tellers warned about from the beginning – that vaccine mandates were never about safety but about pushing dangerous, improperly tested bioweapons as part of the globalist depopulation agenda.
Watch the video below to know more about how COVID-19 vaccines affect reproductive health.
This video is from the AMPNews channel on Brighteon.com.
Sources include:
ZeroHedge.com
BrightU.ai
Brighteon.com
Read full article here